Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Malignant Lymphoma

Free Subscription 30.03.2026 1 Am J Hematol 3 Blood 1 BMC Cancer 2 Br J Haematol 1 Cancer 1 Eur J Haematol 1 J Am Acad Dermatol 1 J Natl Cancer Inst 5 Leuk Lymphoma 1 Leukemia

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. NOOR WD, Seymour JF, Cheah CY
   Marginal Zone Lymphoma: 2026 Update on Diagnosis and Management.
   Am J Hematol. 2026 Mar 23. doi: 10.1002/ajh.70289.
   PubMed         Abstract available
   
   

   
   Blood

2. 
   Ronceray L, Huibers MHW, Reutter K, et al. High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predisposition. Blood. 2026;147(2):209-214.
   Blood. 2026;147:1504.
   PubMed        
   
   
3. 
   Jaye DL, Feldman AL. ALK-negative anaplastic large cell lymphoma with JAK2 rearrangement mimicking classic Hodgkin lymphoma. Blood. 2023;141(17):2160.
   Blood. 2026;147:1504.
   PubMed        
   
   
4. KAMDAR M, Bartlett NL
   From Breakthroughs to Blueprints: Evolving Evidence and Future Directions in Relapsed and Refractory Large B-Cell Lymphoma.
   Blood. 2026 Mar 23:blood.2025030859. doi: 10.1182/blood.2025030859.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. JANG HC, Song GY, Kang SR, Han SJ, et al
   High-risk subgroup and associated genes identified by next generation sequencing in diffuse large B cell lymphoma.
   BMC Cancer. 2026 Mar 23. doi: 10.1186/s12885-026-15868.
   PubMed        
   
   

   
   Br J Haematol

6. LUAN M, Jia R, Wang D, Zhang F, et al
   Early prediction of adult lymphoma-associated haemophagocytic lymphohistiocytosis using an interpretable machine learning model.
   Br J Haematol. 2026 Mar 23. doi: 10.1111/bjh.70447.
   PubMed         Abstract available
   
   
7. CLIFF ERS, McKeague S, Dickinson MJ
   Choosing between Nivo-AVD and BrECADD: Hodgkin lymphoma's new era.
   Br J Haematol. 2026 Mar 23. doi: 10.1111/bjh.70451.
   PubMed        
   
   

   
   Cancer

8. GAO Y, Jiang M, Zhang X, Liu L, et al
   Combination of mitoxantrone hydrochloride liposome with cyclophosphamide, vincristine, and prednisone for patients with treatment-naive peripheral T-cell lymphoma: A multicenter, open-label, single-arm, phase 1b trial.
   Cancer. 2026;132:e70360.
   PubMed         Abstract available
   
   

   
   Eur J Haematol

9. GARCIA CR, Campuzano DM, Ruiz ABG, Moreno ES, et al
   Intravascular Large B-Cell Lymphoma: Clinicopathological Characteristics and Outcomes.
   Eur J Haematol. 2026 Mar 23. doi: 10.1111/ejh.70170.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

10. BALAN K, Lallas A, Akdogan N
    Patterns and Pitfalls: Dermoscopic Differentiation of Early-Stage Mycosis Fungoides, Atopic Dermatitis, and Psoriasis.
    J Am Acad Dermatol. 2025 Dec 17:S0190-9622(25)03431.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

11. GEURTS YM, Neppelenbroek SIM, Aleman BMP, Janus CPM, et al
    Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma.
    J Natl Cancer Inst. 2026 Mar 25:djag085. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

12. JORGENSEN JB, Hansen KV, Nielsen LK, Gade IL, et al
    First-line immunochemotherapy for indolent lymphoma does not affect muscle volume: a post hoc analysis of 472 patients in long-term remissions from the GALLIUM study.
    Leuk Lymphoma. 2026 Mar 25:1-10. doi: 10.1080/10428194.2026.2642931.
    PubMed         Abstract available
    
    
13. KIM DH, Cha S, Koh Y, Byun JM, et al
    Allogeneic hematopoietic stem cell transplantation following T-cell-directed immunotherapy failure in B-cell lymphoma: a real-world case series and systematic literature review.
    Leuk Lymphoma. 2026 Mar 22:1-10. doi: 10.1080/10428194.2026.2638438.
    PubMed         Abstract available
    
    
14. WALTER C, Burger MC, Siebenbrodt K, Mooshage CM, et al
    Spinal cord disease following CAR T-cell therapy with axicabtagene ciloleucel in a patient with high-grade B-cell lymphoma.
    Leuk Lymphoma. 2026 Mar 22:1-5. doi: 10.1080/10428194.2026.2647957.
    PubMed        
    
    
15. GONG IY, Kuruvilla J
    Management of relapsed/refractory DLBCL in the era of novel agents and new approaches.
    Leuk Lymphoma. 2026;67:756-784.
    PubMed         Abstract available
    
    
16. KLEBANER D, Park NJ, Marar M, Frank M, et al
    Treatment kinetics and local response during and after bridging radiotherapy prior to CAR-T cell therapy for lymphomas.
    Leuk Lymphoma. 2026;67:813-820.
    PubMed         Abstract available
    
    

    
    Leukemia

17. YANG Y, Tang Z, Hu Q, Yang P, et al
    Targeting UHRF1 induces regression of aggressive mantle cell lymphoma.
    Leukemia. 2026 Mar 24. doi: 10.1038/s41375-026-02915.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum